...
首页> 外文期刊>The Journal of biological chemistry >A sensitive assay reveals structural requirements for α-synuclein fibril growth
【24h】

A sensitive assay reveals structural requirements for α-synuclein fibril growth

机译:灵敏的测定揭示了α-突触核蛋白原纤维生长的结构要求

获取原文
           

摘要

The accumulation of α-synuclein (α-syn) fibrils in neuronal inclusions is the defining pathological process in Parkinson's disease (PD). A pathogenic role for α-syn fibril accumulation is supported by the identification of dominantly inherited α-syn (SNCA) gene mutations in rare cases of familial PD. Fibril formation involves a spontaneous nucleation event in which soluble α-syn monomers associate to form seeds, followed by fibril growth during which monomeric α-syn molecules sequentially associate with existing seeds. To better investigate this process, we developed sensitive assays that use the fluorescein arsenical dye FlAsH (fluorescein arsenical hairpin binder) to detect soluble oligomers and mature fibrils formed from recombinant α-syn protein containing an N-terminal bicysteine tag (C2-α-syn). Using seed growth by monomer association (SeGMA) assays to measure fibril growth over 3 h in the presence of C2-α-syn monomer, we observed that some familial PD-associated α-syn mutations (i.e. H50Q and A53T) greatly increased growth rates, whereas others (E46K, A30P, and G51D) decreased growth rates. Experiments with wild-type seeds extended by mutant monomer and vice versa revealed that single-amino acid differences between seed and monomer proteins consistently decreased growth rates. These results demonstrate that α-syn monomer association during fibril growth is a highly ordered process that can be disrupted by misalignment of individual amino acids and that only a subset of familial-PD mutations causes fibril accumulation through increased fibril growth rates. The SeGMA assays reported herein can be utilized to further elucidate structural requirements of α-syn fibril growth and to identify growth inhibitors as a potential therapeutic approach in PD.
机译:神经元内含物中α-突触核蛋白(α-syn)原纤维的积累是帕金森氏病(PD)的定义病理过程。在罕见的家族性PD中,通过鉴定显性遗传的α-syn(SNCA)基因突变,可以支持α-syn原纤维积聚的致病作用。原纤维形成涉及自发成核事件,其中可溶性α-syn单体缔合以形成种子,随后发生原纤维生长,在此过程中单体α-syn分子顺序与现有种子缔合。为了更好地研究此过程,我们开发了灵敏的测定方法,使用荧光素砷染料FlAsH(荧光素砷发夹结合剂)检测可溶性寡聚物和由含有N端双半胱氨酸标签(C2-α-syn的重组α-syn蛋白)形成的成熟原纤维。 )。使用通过单体缔合(SeGMA)进行的种子生长测定在C2-α-syn单体存在下3小时内原纤维的生长,我们观察到一些家族性PD相关的α-syn突变(即H50Q和A53T)大大提高了生长速率,而其他(E46K,A30P和G51D)则降低了增长率。用突变单体延伸的野生型种子进行的实验(反之亦然)表明,种子和单体蛋白之间的单氨基酸差异持续降低了生长速率。这些结果表明,原纤维生长过程中的α-syn单体缔合是一个高度有序的过程,可被单个氨基酸的错位破坏,并且只有家族性PD突变的一部分会通过增加原纤维的生长速率而引起原纤维的积累。本文报道的SeGMA分析可用于进一步阐明α-syn原纤维生长的结构要求,并将生长抑制剂鉴定为PD中潜在的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号